India's longevity startup Foxo launches premium health platform targeting affluent urban population. The Bengaluru-based startup uses advanced systems biology and AI to predict disease risk with 85-90% confidence, addressing India's growing health crisis where cancer cases outpace global averages and cardiovascular disorders cause over a third of deaths. Founded by IIT-Kharagpur graduate Subhendu Panigrahi alongside Akash Gehani and Sanmaya Kumar Dhal, Foxo secured $0.5 million in pre-seed funding from Blume Ventures in March 2025. The platform operates as a premium membership model, providing personalized interventions through doctors, nutritionists, and coaches. With India's elderly population projected to reach 347 million by 2050, Foxo capitalizes on growing demand for longevity solutions among health-conscious, high-income individuals battling lifestyle-related diseases.
Post from MarketNews_en
Log in to interact with content.